Source: International Congress 2015 – CAP: prognostic factors in frail patients
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
shu yazaki (tokyo, Japan), Shu Yazaki, Torahiko Jinta, Naoki Nishimura, Hiroshi Nakaoka, Kohei Okafuji, Atsushi Kitamura, Yutaka Tomishima, Takeshi Kimura, Naohiko Chohnabayashi. The role of procalcitonin in predicting severity and clinical course of aspiration pneumonia. Eur Respir J 2015; 46: Suppl. 59, 2579

Member's Comments

No comment yet.

Related content which might interest you: Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Usefulness of procalcitonin as a predictor for bacteremia and prognosis in severe sepsis Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism Year: 2016 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Performance of early warning score and CURB-65 in predicting severe outcome in community-acquired pneumonia Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Prognostic value of procalcitonin in community-acquired pneumonia Source: Eur Respir J 2011; 37: 384 Year: 2011 Prognostic value of plasma D-dimer level in adults with community-acquired pneumonia – A prospective study Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Source: Eur Respir J 2008; 31: 356-362 Year: 2008 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Correlation of procalcitonin and CRP in community-acquired pneumonia with CRB-65 score and prognosis – results from the German competence network CAPNETZ Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia Year: 2006 YKL-40 and CCL18 predict mortality in patients hospitalised with community-acquired pneumonia; an observational analysis Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Prognostic power of biomarkers to predict in-hospital and postdischarge mortality in community acquired pneumonia Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Predictive factors for true bacteremia and clinical utility of blood cultures as a prognostic tool in patients with community-onset pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Can procalcitonin or C-reactive protein predict supporative lung complications and ARDS at severe community-acquired pneumonia (CAP)? Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Clinical and laboratory predictors of survival in patients with severe community-acquired pneumonia (CAP) Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 The prognostic value of consecutive C-reactive protein measurements in community acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Procalcitonin and D-dimer to predict prognosis and clinical outcomes in severe community-acquired pneumonia (SCAP) patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015